Page last updated: 2024-11-04

tegafur and Cholangitis, Sclerosing

tegafur has been researched along with Cholangitis, Sclerosing in 1 studies

Cholangitis, Sclerosing: Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.

Research Excerpts

ExcerptRelevanceReference
"We report a case of sclerosing cholangitis caused by oral chemotherapy with S-1."1.37[A case of sclerosing cholangitis caused by oral chemotherapy with S-1]. ( Akazawa, Y; Ichikawa, T; Isomoto, H; Miyaaki, H; Morisaki, T; Nakao, K; Ohnita, K; Takeshima, F; Taura, N; Toriyama, H; Yamaguchi, N, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morisaki, T1
Ohnita, K1
Takeshima, F1
Akazawa, Y1
Yamaguchi, N1
Miyaaki, H1
Taura, N1
Ichikawa, T1
Isomoto, H1
Toriyama, H1
Nakao, K1

Other Studies

1 other study available for tegafur and Cholangitis, Sclerosing

ArticleYear
[A case of sclerosing cholangitis caused by oral chemotherapy with S-1].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2011, Volume: 108, Issue:2

    Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Cholangitis, Sclerosing; Drug Combinati

2011